Quidelortho Corp (QDEL) Stock Price, Quote & News

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibo...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 552 1100

Fax: 858 453 4338

Website: www.quidelortho.com

Address:

9975 Summers Ridge Road, San Diego, United States

Chickenstick1 Jul. 14 at 6:12 PM

$QDEL Depending on what they can get for their in office test business, I think this can trade above $30. I bet $ABT makes a bid because they have the cash and manufacturing footprint to make it an extremely profitable segment. But, as for $QDEL the divestiture will immediately make them FCF positive.

0 · Reply

runitback349 Jul. 6 at 6:37 PM

$QDEL pretty bullish consolidation no?

0 · Reply

JFDI Jul. 1 at 2:41 PM

$QDEL post eps drift

0 · Reply

Chickenstick1 Jun. 30 at 1:52 PM

$QDEL haha the bears are just way too complacent . If they spin or sell the POC test business, it improves just about every metric. They should do it. Shares would more than double from here and still trade at a discount to the industry. Accumulate into earnings.

0 · Reply

OnlyFibs Jun. 30 at 12:41 AM

$QDEL - sniped we were all over this one too! #hovdid

0 · Reply

gvnbykplt1903 Jun. 29 at 8:53 PM

$QDEL $30 dollars more please😆

1 · Reply

TALENT_ON_LOAN_FROM_GOD Jun. 29 at 6:07 PM

$INLF IS WOUNDED UP TIGHTER THAN A GNAT’s ASS STRETCHED OUT OVER A BARREL $ASTC $QDEL $TVRD $ZCMD

0 · Reply

StocktwitsNews Jun. 29 at 6:04 PM

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally $QDEL $IJR $AVUV https://stocktwits.com/news/equity/markets/qdel-stock-eyes-best-day-in-over-year-point-of-care-sale-talks-ignite-rally/cZ19Ks5R7Lh

0 · Reply

LewisDaKat Jun. 29 at 6:00 PM

$QDEL QuidelOrtho Corp. (NASDAQ: QDEL) Rises Sharply in 6/29 Early Trading Session https://marketwirenews.com/stock/qdel/news/quidelortho-corp-nasdaq-qdel-rises-sharply-in-6-29-e-5048946399635920.html?utm_source=stocktwits

0 · Reply

topstockalerts Jun. 29 at 5:56 PM

Top Gainers PT2 $AZI $KUST $NNBR $ASTC $QDEL

0 · Reply

QuidelOrtho price target raised to $18 from $13 at Citi

2026-07-01T11:40:22.000Z - 13 days ago

QuidelOrtho price target raised to $12 from $11 at JPMorgan

2026-06-29T15:40:18.000Z - 15 days ago

QuidelOrtho puts point-of-care testing unit up for sale, FT reports

2026-06-29T15:40:10.000Z - 15 days ago

QuidelOrtho surges 33% after FT says company looking to sell point-of-care arm

2026-06-23T11:41:24.000Z - 21 days ago

QuidelOrtho appoints Micah Young as CFO

Jun 23, 2026, 7:12 AM EDT - 21 days ago

QuidelOrtho Appoints Micah Young as Chief Financial Officer

Jun 16, 2026, 11:30 AM EDT - 4 weeks ago

QuidelOrtho Transcript: AGM 2026

Jun 3, 2026, 8:10 AM EDT - 5 weeks ago

QuidelOrtho Transcript: Jefferies Global Healthcare Conference 2026

Jun 2, 2026, 12:20 PM EDT - 6 weeks ago

QuidelOrtho Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 12:20 PM EDT - 6 weeks ago

QuidelOrtho Slides: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 7:12 AM EDT - 6 weeks ago

QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies

May 21, 2026, 9:18 AM EDT - 7 weeks ago

When Blood Compatibility Becomes a Pregnancy Risk

May 20, 2026, 7:00 AM EDT - 7 weeks ago

QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences

May 11, 2026, 11:44 PM EDT - 2 months ago

Hantavirus outbreak: these 3 stocks are poised to rip higher

MMM MRNA

2026-05-07T17:03:10.000Z - 2 months ago

QuidelOrtho price target lowered to $11 from $15 at JPMorgan

2026-05-07T13:04:54.000Z - 2 months ago

QuidelOrtho price target lowered to $12 from $17 at UBS

2026-05-07T12:23:05.000Z - 2 months ago

QuidelOrtho downgraded to Hold from Buy at Jefferies

2026-05-07T08:47:43.000Z - 2 months ago

QuidelOrtho price target lowered to $13 from $30 at Citi

May 5, 2026, 5:00 PM EDT - 2 months ago

QuidelOrtho Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 2 months ago

QuidelOrtho Earnings release: Q1 2026

May 5, 2026, 5:00 PM EDT - 2 months ago

QuidelOrtho Slides: Q1 2026

May 5, 2026, 5:00 PM EDT - 2 months ago

QuidelOrtho Quarterly report: Q1 2026

2026-05-05T20:16:22.000Z - 2 months ago

QuidelOrtho reports adjusted Q1 EPS (4c), consensus 42c

2026-05-05T20:13:22.000Z - 2 months ago

QuidelOrtho sees FY26 adjusted EPS $1.80-$2.00, consensus $2.16

May 5, 2026, 4:05 PM EDT - 2 months ago

QuidelOrtho Reports First Quarter 2026 Financial Results

Apr 27, 2026, 8:00 AM EDT - 2 months ago

QuidelOrtho Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

QuidelOrtho Proxy statement: Proxy filing

Apr 23, 2026, 9:32 AM EDT - 2 months ago

Understanding and Addressing Syphilis Trends - and What's Being Missed

2026-04-20T13:22:22.000Z - 3 months ago

TTP Group announces sale of LEX Diagnostics to QuidelOrtho

Apr 20, 2026, 7:56 AM EDT - 3 months ago

TTP Group Announces the Sale of LEX Diagnostics

2026-04-20T11:15:22.000Z - 3 months ago

QuidelOrtho completes acquisition of LEX Diagnostics

Apr 20, 2026, 7:12 AM EDT - 3 months ago

QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics

2026-04-15T20:26:40.000Z - 3 months ago

QuidelOrtho falls 12% to $15.25 after Q1 revenue guidance misses estimates

Apr 15, 2026, 4:15 PM EDT - 3 months ago

QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance

Mar 24, 2026, 7:00 AM EDT - 4 months ago

Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer

Mar 3, 2026, 1:40 PM EST - 4 months ago

QuidelOrtho Transcript: 47th Annual Raymond James Institutional Investor Conference

Mar 3, 2026, 1:40 PM EST - 4 months ago

QuidelOrtho Slides: 47th Annual Raymond James Institutional Investor Conference

Feb 19, 2026, 9:17 AM EST - 5 months ago